MedTrace Logo

Trial Comparing 19 and 25-gauge EUS-FNA Needles

NCT01677312 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2020-03-17

Study results available
· View outcomes & findings →

Summary

This study compares the 19G and 25G needles for procuring tissue samples from the pancreas during Endoscopic Ultrasound (EUS) procedures.

Conditions

  • Cancer of Pancreas
  • Pancreatic Neoplasm

Interventions

PROCEDURE

Pancreatic Biopsy

A FNA needle will be used to biopsy the pancreatic mass. The rates of diagnostic accuracy (%) will be assessed. Diagnostic accuracy is defined as the proportion of patients in whom a definitive diagnosis can be obtained within a predetermined number of FNA passes.

PROCEDURE

Histological Samples

The proportion of patients (%) in whom a histological tissue can be obtained when performing a biopsy of the pancreas using a specific needle will be assessed.

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER

  • AdventHealth

    lead OTHER

Principal Investigators

  • shyam varadarajulu, MD · Florida Hospital Center for Interventional Endoscopy

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01677312 on ClinicalTrials.gov